This photograph shows the logo of the US artificial intelligence safety and research company Anthropic displayed on a smartphone's screen in Brussels on June 10, 2026. Nicolas TUCAT/Getty Images On ...
8th Pay Commission news: The 8th Pay Commission is set to travel to Chennai on September 7 and 8, following its two-day stakeholders’ consultation meeting in Jaipur. During the Chennai visit, ...
AI Quick Read The 8th Pay Commission completed nine months on 3 August, i.e., half of its allocated time. Soon it will have completed ten months since its constitution. It was constituted on 3 ...
A visit to an online longevity calculator might seem like a morbid exercise. No one wants to think about dying. And one might argue that a life expectancy calculator never dispenses good news. It ...
Investment firm KKR KKR-0.12%decrease; down pointing triangle has struck a deal to acquire medical-device outsourcing company Integer Holdings ITGR 0.05%increase; up pointing triangle for about $4.3 ...
Private equity giant KKR will take Integer Holdings private in an all-cash deal valued at about $5.7 billion, the medical-device outsourcing firm said on Monday. Shares of Plano, Texas-based Integer ...
KKR has agreed to buy US medical device company Integer Holdings Corp. in an all-cash deal valued at about $5.7 billion. Integer stockholders will receive $127 per share under terms of the deal that ...
KKR will pay $127 per share in cash; deal includes assumption of Integer's debt Acquisition will deepen KKR's healthcare exposure Integer supplies cardiac, pain-management components to major ...
WSJ Buy Side is The Wall Street Journal’s research and commerce team. Our commerce content is distinct from our newsroom coverage. We earn a commission from some links in our articles. Learn more.
July 31 (Reuters) - Private equity firm KKR (KKR.N), opens new tab is nearing a takeover of medical device outsourcing company Integer Holdings (ITGR.N), opens new tab, the Wall Street Journal ...
Integer Holdings Corp. is a unique, high-quality medical device CDMO trading at a depressed ~10x EBITDA multiple after a temporary growth slowdown. A strategic review, prompted by activist involvement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results